SI
LEGN icon

Symmetry Investments’s Legend Biotech LEGN Stock Holding History

Symmetry Investments’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-36,200
Closed -$1.28M – 168
2025
Q2 		$1.28M Buy
+36,200
New +$1.17M 0.09% 93

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Symmetry Investments's LEGN Position: Q3 2025 in Review

Symmetry Investments sold out of Legend Biotech (LEGN) in Q3 2025, closing a stake of 36,200 shares — an estimated $1.28M sold.

Symmetry Investments first reported a position in LEGN in Q2 2025 and held it in 1 quarter. The position peaked at $1.28M in Q2 2025. 199 funds tracked by Wall St. Rank hold LEGN as of Q3 2025.

  • Symmetry Investments reported no remaining Legend Biotech position as of Q3 2025 after selling out during the quarter.
  • Symmetry Investments sold 36,200 Legend Biotech shares in Q3 2025, an estimated $1.28M.
  • Symmetry Investments first reported a position in Legend Biotech in Q2 2025 and held it in 1 quarter.
  • Symmetry Investments's Legend Biotech position peaked at $1.28M in Q2 2025.
  • 199 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2025.

Based on Symmetry Investments's 13F filing for Q3 2025, filed 14 Nov 2025.